• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    56.13 Down 1.03(1.80%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:57.16
    Open:57.10
    Bid:55.50 x 600
    Ask:55.99 x 2900
    1y Target Est:68.78
    Beta:2.16
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:55.77 - 57.16
    52wk Range:27.37 - 77.80
    Volume:1,521,862
    Avg Vol (3m):2,435,700
    Market Cap:6.72B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ISIS

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 1.80%6.72B
    ENZDown 1.36%134.03M
    GILDDown 0.84%169.06B
    SRPTUp 1.31%1.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):27.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.30
    Quarterly EPS Est (Jun-15) :0.31
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-8.98

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback